John Overdeck’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Buy
89,200
+45,500
+104% +$9.8M 0.02% 991
2026
Q1
$8.78M Buy
43,700
+1,000
+2% +$207K 0.01% 1489
2025
Q4
$8.82M Buy
42,700
+31,400
+278% +$6.27M 0.01% 1206
2025
Q3
$2.03M Sell
11,300
-400
-3% -$68.1K ﹤0.01% 2115
2025
Q2
$1.89M Sell
11,700
-36,100
-76% -$5.75M ﹤0.01% 1877
2025
Q1
$8.13M Buy
47,800
+30,715
+180% +$5.33M 0.02% 854
2024
Q4
$2.84M Buy
17,085
+385
+2% +$65.8K 0.01% 1476
2024
Q3
$2.87M Buy
16,700
+13,900
+496% +$2.3M 0.01% 1443
2024
Q2
$431K Sell
2,800
-3,200
-53% -$480K ﹤0.01% 2432
2024
Q1
$923K Buy
6,000
+4,200
+233% +$640K ﹤0.01% 2001
2023
Q4
$284K Buy
+1,800
New +$259K ﹤0.01% 2715
2023
Q3
Sell
-14,600
Closed -$2.24M 3029
2023
Q2
$2.24M Buy
14,600
+8,100
+125% +$1.26M 0.01% 1365
2023
Q1
$1.01M Sell
6,500
-1,300
-17% -$204K ﹤0.01% 1858
2022
Q4
$1.2M Buy
7,800
+5,100
+189% +$752K ﹤0.01% 1611
2022
Q3
$356K Buy
+2,700
New +$379K ﹤0.01% 1908

Other funds holding FBT

John Overdeck's FBT Position: Q2 2026 in Review

John Overdeck increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 104% in Q2 2026, buying an estimated $9.8M and bringing the position to 89,200 shares worth $22.1M. The position accounts for 0.02% of the portfolio, ranked #991.

John Overdeck first reported a position in FBT in Q3 2022 and has held it in 15 quarters since. 338 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • John Overdeck held 89,200 shares of First Trust NYSE Arca Biotechnology Index Fund worth $22.1M as of Q2 2026.
  • John Overdeck bought 45,500 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $9.8M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of John Overdeck's portfolio in Q2 2026, its #991 holding.
  • John Overdeck first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and has held it in 15 quarters since.
  • 338 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.